pirtobrutinib
eli lilly
['mantle,(-dismantle)', 'lymsm', 'oval,(-approval)', 'lymphoma']
at #eha2022, see updated results from the phase 1/2 bruin study, assessing a highly selective, reversible (non-covalent) #btki in previously treated mantle cell #lymphoma. view presentation details here: #mcl #lymsm 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK